Abstract:OBJECTIVES:Deguelin, a rotenoid extracted from Mundulea sericea (Leguminosae), exhibits antitumor effects on several types of human cancers. Due to the limited studies of deguelin on colorectal cancer (CRC), the present study was designed to investigate the antitumor effect of deguelin and to explore the underlying mechanism in CRC.MATERIALS AND METHODS:Cell viability was assessed by the cell counting kit-8 (CCK-8) assay, and cell apoptosis was determined by the annexin v-propidium iodide staining using flow cytometry and Western blot in CRC cell lines after incubation with deguelin. The antitumor effect of deguelin was further evaluated in tumor xenograft models. Moreover, SB203580, a specific inhibitor of p38 MAPK, was used to confirm the involvement of p38 MAPK pathway in deguelin-induced apoptosis.RESULTS:Deguelin significantly inhibited cell proliferation and induced apoptosis in CRC cell lines (SW620 and RKO) in a time-dependent and dose-dependent manner. Western blot analysis also showed that the expression of proapoptotic proteins (cleaved caspase 3 and cleaved PARP) was upregulated, while that of antiapoptotic proteins (Bcl-2 and survivin) was downregulated after deguelin treatment in CRC cell lines. Moreover, oral administration of deguelin significantly suppressed tumor growth and induced apoptosis in subcutaneous xenograft mouse models without obvious toxicity. Additionally, Western blot revealed that deguelin-induced apoptosis might be regulated by the p38 MAPK pathway and inhibition of p38 MAPK could attenuate deguelin-induced proliferative inhibition and apoptosis in CRC cells.CONCLUSION:Collectively, these results demonstrated that deguelin inhibited CRC cell growth by inducing apoptosis via activation of p38 MAPK pathway.

The effect of deguelin on expression of topol in K562 cells

[Effect of Deguelin on Expression of Nup98 in K562 Cells].

Deguelin Induces Apoptosis in Colorectal Cancer Cells by Activating the P38 MAPK Pathway.

Effects of deguelin on proliferation and apoptosis of gastric cancer cells MKN-45

Deguelin Regulates Nuclear Pore Complex Proteins Nup98 and Nup88 in U937 Cells in Vitro

[Inhibition Effect of Topotecan on Human Myelodysplastic Syndrome Cells in Vitro and in Vivo].

Deguelin Attenuates Non-Small-Cell Lung Cancer Cell Metastasis by Upregulating PTEN/KLF4/EMT Signaling Pathway.

Studies on the Mechanism of Deguelin-induced Apoptosis of Human Prostate Cancer Cell Lines

Study on the Effect of Curcumin on TopoⅠ of K562 Cell

Deguelin Impairs Cell Adhesion, Migration And Invasion Of Human Lung Cancer Cells Through The Nf-Kappa B Signaling Pathways

Effect of Deguelin on proliferation and apoptosis of lymphoma Daudi cells and its mechanism

Antitumor Effects of Deguelin on H460 Human Lung Cancer Cells in Vitro and in Vivo: Roles of Apoptotic Cell Death and H460 Tumor Xenografts Model.

Study of Proliferation Inhibition and Apoptosis Induction of Deguelin in Human Hepatocellular Cancer Cell Line SMMC-7721

Regulatory effects of deguelin on proliferation and cell cycle of Raji cells

Regulating Expressions of Cyclin D1, Prb, and Anti-Cancer Effects of Deguelin on Human Burkitt'S Lymphoma Daudi Cells in Vitro

Deguelin Impairs Cell Adhesion, Migration and Invasion of Human Lung Cancer Cells through the NF-[Formula: see text]B Signaling Pathways.

Deguelin inhibits expression of IkappaBalpha protein in Raji and U937 cells.

Deguelin Induces The Apoptosis Of Lung Squamous Cell Carcinoma Cells Through Regulating The Expression Of Galectin-1

Deguelin Inhibits Proliferation and Migration of Human Pancreatic Cancer Cells in Vitro Targeting Hedgehog Pathway.

Deguelin inhibits the glioblastoma progression through suppressing CCL2/NFκB signaling pathway

Deguelin Represses Both The Expression Of Nucleophosmin And Some Nucleoporins: Nup88 And Nup214 In Jurkat Cells